HopeStage
Back to all studies
CompletedNCT01748955

Paroxetine or Bupropion and Brain Reward Activity in Depression

About this title

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Read the official source — NCT01748955
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2010
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT01748955
Official title
Show the full official title

SSRI Versus Bupropion in High-Risk Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Did this study involve medication?

Yes. The study involved medication, including Paroxetine CR for Major Depressive Episode and Bupropion XL for Major Depressive Episode.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies